Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02687035 · ClinicalTrials.gov registry record · NA
PARTNER II Trial: S3iCAP
A NA study of Aortic Stenosis, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- NA
- Development phase
- 1,822
- Enrollment target
- 20
- Study locations
NCT02687035 is a NA study of Aortic Stenosis that has completed, run by Edwards Lifesciences. The registered enrollment target is 1,822 participants, above the 1,292-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (41% higher). The trial reports 20 study locations across 11 states.
The verdict
NCT02687035, a NA study of Aortic Stenosis, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,822 participants
- Enrollment target
- 20
- Study locations
Study Summary
Following completion of enrollment in the PARTNER II SAPIEN 3 intermediate risk trial, this trial provided continued access to treatment for subjects with severe aortic stenosis who were at intermediate surgical risk.
Conditions Studied
Interventions
- DEVICE SAPIEN S3 valve
Study Locations (20)
California
- Scripps Green Hospital - La Jolla
- Cedars-Sinai Medical Center - Los Angeles
- Stanford Hospital and Clinics - Palo Alto
- Mercy General Hospital - Sacramento
Illinois
- Northwestern University - Chicago
- Rush University Medical Center - Chicago
- NorthShore University HealthSystem Research Institute - Evanston
- Prairie Education and Research Cooperative - Springfield
Florida
- Morton Plant Hospital - Clearwater
- University of Florida - Gainesville
Indiana
- Indiana University Health-Methodist Hospital - Indianapolis
- St. Vincent Medical Group, Inc./ St. Vincent Heart Center of Indiana, LLC - Indianapolis
Maryland
- MedStar Union Memorial Hospital - Baltimore
- University of Maryland Medical Center - Baltimore
Colorado
- University of Colorado Hospital - Denver
District of Columbia
- Washington Hospital Center DC - Washington D.C.
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,822 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02687035
The ClinicalTrials.gov registry entry for NCT02687035 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,822 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,292-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (41% higher). The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Stenosis appearing as the primary indexed condition, and to 1 intervention - of which SAPIEN S3 valve is the first listed.
NCT02687035 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Illinois, Florida.
Frequently Asked Questions
What is clinical trial NCT02687035 about?
NCT02687035 is a clinical study titled "PARTNER II Trial: S3iCAP". Following completion of enrollment in the PARTNER II SAPIEN 3 intermediate risk trial, this trial provided continued access to treatment for subjects with severe aortic stenosis who were at intermediate surgical risk.
What is the current status of trial NCT02687035?
This trial is currently completed. It is a NA study. The enrollment target is 1,822 participants. The study started on 2015-01. Estimated completion is 2018-12.
What conditions does trial NCT02687035 study?
This clinical trial studies the following conditions: Aortic Stenosis.
What interventions are being tested in trial NCT02687035?
The interventions under investigation include: SAPIEN S3 valve (DEVICE).
Who is sponsoring clinical trial NCT02687035?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02687035 being conducted?
This trial has 20 study locations across California, Colorado, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
RECRUITING · NA
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
-
Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
RECRUITING · NA
-
PARTNER 3 Trial - Aortic Valve-in-Valve
RECRUITING · NA
-
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
RECRUITING · NA
-
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.